| LDR | 01042cam a2200313 a 4500 | ||
| 001 | 007416835 | ||
| 003 | MiAaHDL | ||
| 005 | 20111213000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 971021s1996 dcua f000 0 spa d | ||
| 035 | ⊔ | ⊔ | ‡asdr-umn002511119 |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)37817447 |
| 035 | ⊔ | ⊔ | ‡a(GPO)97085743 |
| 035 | ⊔ | ⊔ | ‡a(MvI)97111909 |
| 035 | ⊔ | ⊔ | ‡a(MnU)notisARK6997 |
| 040 | ⊔ | ⊔ | ‡aDGPO ‡cDGPO ‡dDLC ‡dMvI |
| 041 | 0 | ⊔ | ‡aspa |
| 049 | ⊔ | ⊔ | ‡aMNUA ‡aMNPA |
| 074 | ⊔ | ⊔ | ‡a0475 |
| 086 | 0 | ⊔ | ‡aHE 20.4002:T 32/996/SPAN. |
| 099 | ⊔ | ⊔ | ‡aHE 20.4002:T 32/996/SPAN. |
| 245 | 0 | 3 | ‡aLa Talidomida : ‡bimportante informacion para el paciente. |
| 260 | ⊔ | ⊔ | ‡a[Washington, D.C.? : ‡bHealth and Human Services, Public Health Service, Food and Drug Administration, ‡c1996?] |
| 300 | ⊔ | ⊔ | ‡a1 folded sheet (6 p.) : ‡bill. ; ‡c22 x 10 cm. |
| 490 | ⊔ | 0 | ‡aDHHS publication; ‡vno. (FDA) 96-3222 S |
| 500 | ⊔ | ⊔ | ‡aShipping list no.: 97-0374-P. |
| 500 | ⊔ | ⊔ | ‡aCaption title. |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 546 | ⊔ | ⊔ | ‡aText in Spanish. |
| 650 | ⊔ | 0 | ‡aThalidomide ‡xSide effects. |
| 710 | 1 | ⊔ | ‡aUnited States. ‡bFood and Drug Administration |
| CID | ⊔ | ⊔ | ‡a007416835 |
| DAT | 0 | ⊔ | ‡a20100105095455.0 ‡b20111213000000.0 |
| DAT | 1 | ⊔ | ‡a20120815122756.0 ‡b2023-02-24T18:55:31Z |
| CAT | ⊔ | ⊔ | ‡aSDR-UMN ‡dUNKNOWN ‡lloader.pl-001-001 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-umn002511119 ‡aumn ‡bSDR ‡cUMN ‡pumn.31951d01557506n ‡sUMN ‡1002511119 |
| 974 | ⊔ | ⊔ | ‡bUMN ‡cUMN ‡d20230224 ‡sgoogle ‡uumn.31951d01557506n ‡y1996 ‡rpd ‡qbib ‡tUS fed doc |